Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

NOV/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance.

Martinerie C, Garcia M, Do TT, Antoine B, Moldes M, Dorothee G, Kazazian C, Auclair M, Buyse M, Ledent T, Marchal PO, Fesatidou M, Beisseiche A, Koseki H, Hiraoka S, Chadjichristos CE, Blondeau B, Denis RG, Luquet S, Fève B.

Diabetes. 2016 Sep;65(9):2502-15. doi: 10.2337/db15-0617. Epub 2016 Jun 9.

2.

Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.

Marchal PO, Kavvadas P, Abed A, Kazazian C, Authier F, Koseki H, Hiraoka S, Boffa JJ, Martinerie C, Chadjichristos CE.

PLoS One. 2015 Sep 14;10(9):e0137876. doi: 10.1371/journal.pone.0137876. eCollection 2015.

3.

Plasma NOV/CCN3 levels are closely associated with obesity in patients with metabolic disorders.

Pakradouni J, Le Goff W, Calmel C, Antoine B, Villard E, Frisdal E, Abifadel M, Tordjman J, Poitou C, Bonnefont-Rousselot D, Bittar R, Bruckert E, Clément K, Fève B, Martinerie C, Guérin M.

PLoS One. 2013 Jun 13;8(6):e66788. doi: 10.1371/journal.pone.0066788. Print 2013.

4.

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9.

Kular L, Rivat C, Lelongt B, Calmel C, Laurent M, Pohl M, Kitabgi P, Melik-Parsadaniantz S, Martinerie C.

J Neuroinflammation. 2012 Feb 21;9:36. doi: 10.1186/1742-2094-9-36.

5.

Temporal and spatial expression of CCN3 during retina development.

Laurent M, Le Dréau G, Guillonneau X, Lelièvre E, Slembrouck A, Goureau O, Martinerie C, Marx M.

Dev Neurobiol. 2012 Nov;72(11):1363-75. doi: 10.1002/dneu.20994. Epub 2012 Jul 13. Erratum in: Dev Neurobiol. 2013 Mar;73(3):257. Maryvonne, Laurent [corrected to Laurent, Maryvonne]; Gwenvaël, Le Dréau [corrected to Le Dréau, Gwenvaël]; Xavier, Guillonneau [corrected to Guillonneau, Xavier]; Cecile, Lelièvre Elise [corrected to Lelièvre, Elise]; Amèlie, Slembrouck [corrected.

6.

The CCN family: a new class of inflammation modulators?

Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C.

Biochimie. 2011 Mar;93(3):377-88. doi: 10.1016/j.biochi.2010.11.010. Epub 2010 Dec 2. Review.

PMID:
21130134
7.

NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins.

Le Dréau G, Kular L, Nicot AB, Calmel C, Melik-Parsadaniantz S, Kitabgi P, Laurent M, Martinerie C.

Glia. 2010 Sep;58(12):1510-21. doi: 10.1002/glia.21025.

PMID:
20648642
8.

NOV/CCN3 promotes maturation of cerebellar granule neuron precursors.

Le Dréau G, Nicot A, Bénard M, Thibout H, Vaudry D, Martinerie C, Laurent M.

Mol Cell Neurosci. 2010 Jan;43(1):60-71. doi: 10.1016/j.mcn.2009.02.011. Epub 2009 Mar 13.

PMID:
19286457
9.

Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.

Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S, West AN, Laurent M, Mas JC, Bongain A, Zambetti GP, Figueiredo BC, Auberger P, Martinerie C, Lalli E.

J Clin Endocrinol Metab. 2007 Aug;92(8):3253-60. Epub 2007 Jun 12.

PMID:
17566092
10.

Expression of matrix metalloproteinases MMP-2 and MMP-9 is altered during nephrogenesis in fetuses from diabetic rats.

Duong Van Huyen JP, Viltard M, Nehiri T, Freund N, Bélair MF, Martinerie C, Lelongt B, Bruneval P, Lelièvre-Pégorier M.

Lab Invest. 2007 Jul;87(7):680-9. Epub 2007 May 14.

11.

NOV/CCN3 impairs muscle cell commitment and differentiation.

Calhabeu F, Lafont J, Le Dreau G, Laurent M, Kazazian C, Schaeffer L, Martinerie C, Dubois C.

Exp Cell Res. 2006 Jun 10;312(10):1876-89. Epub 2006 Apr 5.

PMID:
16600215
12.

NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival.

Lafont J, Thibout H, Dubois C, Laurent M, Martinerie C.

Cell Commun Adhes. 2005 Jan-Apr;12(1-2):41-57.

PMID:
16371345
13.

New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.

Lafont J, Jacques C, Le Dreau G, Calhabeu F, Thibout H, Dubois C, Berenbaum F, Laurent M, Martinerie C.

J Bone Miner Res. 2005 Dec;20(12):2213-23. Epub 2005 Aug 22. Erratum in: J Bone Miner Res. 2006 Feb;21(2):352.

14.

NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism.

Laurent M, Martinerie C, Thibout H, Hoffman MP, Verrecchia F, Le Bouc Y, Mauviel A, Kleinman HK.

FASEB J. 2003 Oct;17(13):1919-21. Epub 2003 Aug 15.

PMID:
14519668
15.

Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system.

Thibout H, Martinerie C, Créminon C, Godeau F, Boudou P, Le Bouc Y, Laurent M.

J Clin Endocrinol Metab. 2003 Jan;88(1):327-36.

PMID:
12519873
16.

The expression of novH in adrenocortical cells is down-regulated by TGFbeta 1 through c-Jun in a Smad-independent manner.

Lafont J, Laurent M, Thibout H, Lallemand F, Le Bouc Y, Atfi A, Martinerie C.

J Biol Chem. 2002 Oct 25;277(43):41220-9. Epub 2002 Jul 30.

17.

Altered expression of novH is associated with human adrenocortical tumorigenesis.

Martinerie C, Gicquel C, Louvel A, Laurent M, Schofield PN, Le Bouc Y.

J Clin Endocrinol Metab. 2001 Aug;86(8):3929-40.

PMID:
11502835
18.
19.

novH: differential expression in developing kidney and Wilm's tumors.

Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B.

Am J Pathol. 1998 Jun;152(6):1563-75.

20.

Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system.

Martinerie C, Viegas-Pequignot E, Nguyen VC, Perbal B.

Mol Pathol. 1997 Dec;50(6):310-6.

21.

Genomic structure and chromosomal mapping of the mouse nov gene.

Snaith MR, Natarajan D, Taylor LB, Choi CP, Martinerie C, Perbal B, Schofield PN, Boulter CA.

Genomics. 1996 Dec 15;38(3):425-8.

PMID:
8975721
22.

Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines.

Zumkeller W, Biernoth R, Kocialkowski S, Martinerie C, Schofield P, Perbal B, Westphal M.

Int J Oncol. 1996 Nov;9(5):983-92.

PMID:
21541605
23.

Regulation of nov by WT1: a potential role for nov in nephrogenesis.

Martinerie C, Chevalier G, Rauscher FJ 3rd, Perbal B.

Oncogene. 1996 Apr 4;12(7):1479-92.

PMID:
8622864
24.

Differential expression of novH and CTGF in human glioma cell lines.

Xin LW, Martinerie C, Zumkeller W, Westphal M, Perbal B.

Clin Mol Pathol. 1996 Apr;49(2):M91-7.

25.

Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src.

Scholz G, Martinerie C, Perbal B, Hanafusa H.

Mol Cell Biol. 1996 Feb;16(2):481-6.

26.

Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.

Martinerie C, Huff V, Joubert I, Badzioch M, Saunders G, Strong L, Perbal B.

Oncogene. 1994 Sep;9(9):2729-32.

PMID:
7520150
27.

Physical mapping of human loci homologous to the chicken nov proto-oncogene.

Martinerie C, Viegas-Pequignot E, Guenard I, Dutrillaux B, Nguyen VC, Bernheim A, Perbal B.

Oncogene. 1992 Dec;7(12):2529-34.

PMID:
1334251
28.

A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.

Vellard M, Sureau A, Soret J, Martinerie C, Perbal B.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2511-5.

29.

Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products.

Merzak A, Soret J, Martinerie C, Sureau A, Crochet J, Perbal B.

Oncogene. 1992 Mar;7(3):535-42.

PMID:
1549366
30.

Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas.

Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B.

Mol Cell Biol. 1992 Jan;12(1):10-21.

31.

v-myb transformation of Xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells.

Michelin S, Varlet I, Martinerie C, Perbal B, Sarasin A, Suárez HG.

Exp Cell Res. 1991 Oct;196(2):314-22.

PMID:
1893942
32.

Expression of a gene encoding a novel potential IGF binding protein in human tissues.

Martinerie C, Perbal B.

C R Acad Sci III. 1991;313(8):345-51.

PMID:
1756408
33.

The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2.

Martinerie C, Cannizzaro LA, Croce CM, Huebner K, Katzav S, Barbacid M.

Hum Genet. 1990 Nov;86(1):65-8.

PMID:
2253939
34.

Translocations and rearrangements in T-cell acute leukemias with the t(11;14) (p13;q11) chromosomal translocations.

Harvey RC, Martinerie C, Sun LH, Williams D, Showe LC.

Oncogene. 1989 Mar;4(3):341-9. Erratum in: Oncogene 1989 Aug;4(8):1057. Marteneire C [corrected to Martinerie C].

PMID:
2523031
35.

Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription.

Soret J, Vellard M, Martinerie C, Perbal B.

FEBS Lett. 1988 May 9;232(1):227-34.

36.

myb-specific probes.

Martinerie C, Soret J, Perbal B.

Nucleic Acids Res. 1987 Feb 11;15(3):1329-30. No abstract available.

Supplemental Content

Loading ...
Support Center